TCG Crossover Management, LLC
PALO ALTO, CA · CIK 1839948 · 13F filing filed 2024-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyPalo Alto, CA
$959.5m
reported value
-24.1% vs Q1 2024
32positions
64.7%in top 10
2 new
6 added
4 reduced
3 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $115.9m12.08% | Added +100.0k |
| DYNE THERAPEUTICS INC DYN | $93.5m9.75% | Unchanged |
| ABIVAX SA ABVX | $80.1m8.34% | Added +5.0m |
| SILENCE THERAPEUTICS PLC SLN | $62.6m6.53% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $58.7m6.12% | Added +750.0k |
| SAVARA INC SVRA | $49.8m5.19% | Added +2.4m |
| MADRIGAL PHARMACEUTICALS INC MDGL | $41.8m4.36% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $40.9m4.27% | Unchanged |
| KEROS THERAPEUTICS INC KROS | $40.2m4.19% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $37.3m3.88% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $36.4m3.79% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $31.8m3.31% | Unchanged |
| KURA ONCOLOGY INC KURA | $29.3m3.06% | Unchanged |
| STRUCTURE THERAPEUTICS INC GPCR | $27.3m2.84% | Reduced -903.9k |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $26.1m2.72% | Added +850.0k |
| ASTRIA THERAPEUTICS INC CATB | $25.1m2.62% | Reduced -2.5m |
| COMPASS PATHWAYS PLC CMPS | $23.3m2.43% | Unchanged |
| SOLENO THERAPEUTICS INC SLNO | $22.4m2.34% | Unchanged |
| DISC MEDICINE INC IRON | $21.9m2.29% | New |
| TOURMALINE BIO INC TRML | $19.0m1.98% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $15.1m1.58% | Reduced -237.5k |
| ADVERUM BIOTECHNOLOGIES INC COM | $13.8m1.44% | Unchanged |
| VISTAGEN THERAPEUTICS INC VTGN | $9.3m0.97% | Unchanged |
| ENTRADA THERAPEUTICS INC TRDA | $8.3m0.87% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $8.0m0.84% | New |
| C4 THERAPEUTICS INC CCCC | $5.9m0.61% | Unchanged |
| NEKTAR THERAPEUTICS COM | $5.0m0.52% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $3.7m0.39% | Added +39.5k |
| AN2 THERAPEUTICS INC ANTX | $3.3m0.35% | Unchanged |
| KODIAK SCIENCES INC KOD | $2.1m0.22% | Unchanged |
| VENTYX BIOSCIENCES INC VTYX | $730.4k0.08% | Reduced -499.5k |
| CABALETTA BIO INC CABA | $649.2k0.07% | Unchanged |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| INHIBRX INC INBX | $61.2m1.8m shares |
| GERON CORP GERN | $57.4m17.4m shares |
| KALVISTA PHARMACEUTICALS INC KALV | $13.8m1.2m shares |